UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$188M |
| 2 |
Yelp
YELP
|
+$182M |
| 3 |
General Motors
GM
|
+$141M |
| 4 |
American Express
AXP
|
+$138M |
| 5 |
Comcast
CMCSA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$331M |
| 2 |
Crown Castle
CCI
|
+$303M |
| 3 |
Cardinal Health
CAH
|
+$204M |
| 4 |
Gilead Sciences
GILD
|
+$157M |
| 5 |
Apple
AAPL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.6% |
| 2 | Healthcare | 13.9% |
| 3 | Technology | 13.4% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
BWX Technologies
BWXT
$15.5B
| $7.94M | 0.01% |
324,793
+201,091
| +163% | +$4.71M |
|
|
OREX
852
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $7.92M | 0.01% |
140,755
-16,555
| -11% | -$930K |
|
|
ORB
853
DELISTED
ORBITAL SCIENCES CORP
ORB
| $7.9M | 0.01% |
338,998
+77,800
| +30% | +$1.78M |
|
|
HW
854
DELISTED
Headwaters Inc
HW
| $7.84M | 0.01% |
800,295
+237,700
| +42% | +$2.19M |
|
855
Centene
CNC
$30.7B
| $7.81M | 0.01% |
529,992
+245,200
| +86% | +$3.67M |
|
856
Essent Group
ESNT
$6.08B
| $7.76M | 0.01% |
+322,500
| New | +$7.08M |
|
857
CubeSmart
CUBE
$9.39B
| $7.74M | 0.01% |
485,469
-7,900
| -2% | -$136K |
|
858
Pediatrix Medical
MD
$2.18B
| $7.71M | 0.01% |
144,426
-5,358
| -4% | -$288K |
|
|
TCS
859
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $7.63M | 0.01% |
+10,913
| New | +$6.42M |
|
|
INVX
860
Innovex International
INVX
$1.96B
| $7.63M | 0.01% |
69,359
+3,370
| +5% | +$381K |
|
861
Wabash National
WNC
$512M
| $7.62M | 0.01% |
617,303
-30,792
| -5% | -$368K |
|
862
Skyworks Solutions
SWKS
$9.37B
| $7.61M | 0.01% |
266,517
-3,225,977
| -92% | -$84.5M |
|
863
Williams-Sonoma
WSM
$26.9B
| $7.56M | 0.01% |
259,592
-8,768
| -3% | -$245K |
|
864
Mitsubishi UFJ Financial
MUFG
$253B
| $7.53M | 0.01% |
1,127,824
+97,596
| +9% | +$626K |
|
865
Rio Tinto
RIO
$158B
| $7.45M | 0.01% |
132,087
+4,313
| +3% | +$224K |
|
866
Telefônica Brasil
VIV
$20.6B
| $7.42M | 0.01% |
386,226
-11,200
| -3% | -$227K |
|
|
ICPT
867
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $7.41M | 0.01% |
+108,500
| New | +$6.27M |
|
|
ACC
868
DELISTED
American Campus Communities, Inc.
ACC
| $7.4M | 0.01% |
229,661
+611
| +0.3% | +$20.5K |
|
869
Petrobras
PBR
$125B
| $7.38M | 0.01% |
535,495
-19,700
| -4% | -$306K |
|
870
Dr. Reddy's Laboratories
RDY
$9.87B
| $7.36M | 0.01% |
896,750
-7,500
| -0.8% | -$59.4K |
|
871
Prudential
PUK
$37.6B
| $7.35M | 0.01% |
168,470
+292
| +0.2% | +$11.6K |
|
|
HAR
872
DELISTED
Harman International Industries
HAR
| $7.35M | 0.01% |
89,783
+6,701
| +8% | +$518K |
|
873
Global Payments
GPN
$23B
| $7.34M | 0.01% |
226,026
+5,400
| +2% | +$164K |
|
874
Amdocs
DOX
$5.92B
| $7.34M | 0.01% |
178,033
+4,918
| +3% | +$193K |
|
|
SGEN
875
DELISTED
Seagen Inc. Common Stock
SGEN
| $7.29M | 0.01% |
182,862
-78,328
| -30% | -$3.2M |
|
Similar funds
UBS AM's Q4 2013 Portfolio in Review
As of Q4 2013, UBS AM held 2,637 positions worth $87.5B, up 8.1% from $80.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2013 filing shows 130 new, 1,010 increased, 1,128 reduced and 103 closed positions. Its largest new stake was Trip.com Group: 2,309,000 shares worth $57.3M. The largest sale was eBay, an estimated $331M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- UBS AM's largest Q4 2013 buy was Trip.com Group: 2,309,000 shares worth $57.3M.
- UBS AM added most to Regeneron Pharmaceuticals in Q4 2013, an estimated $188M increase.
- UBS AM's biggest Q4 2013 reduction was eBay, cutting an estimated $331M.
- UBS AM fully exited DELL INC in Q4 2013, selling an estimated $62.9M.
- UBS AM's ten largest holdings make up 14% of its $87.5B portfolio in Q4 2013.
- UBS AM opened 130 new positions and closed 103 in Q4 2013.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $87.5B.
Based on UBS AM's 13F filing for Q4 2013, filed 31 Jan 2014.